Clinical Trial Update: Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Fotemustine to intensive surveillance in high-risk uveal melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Fotemustine (fotemustine)

Snippet

Sponsor: Institut Curie | Conditions: Uveal Melanoma | Phase 3 | Status: COMPLETED